|
|
 |
News |
21.05.2010
A registration procedure of Pergoveris, a new drug to treat infertility, is completed.
A new drug Pergoveris to treat infertility is registered. Pergoveris is a combination of follitropin alfa (r-hFSH) 150 IU and lutropin alfa (r-hLH) 75 IU. Pergoveris is a highly effective, safe and easy to use drug in ART due to recombinant technology and FSH and LH optimal ratio. For more information, please click http://www.merckserono.com/en/therapeutic_areas/fertility/infertility/pergoveris/pergoveris.html
| 15.11.2011 |
III Kazakh International scientific conference of KARM “Present approaches in infertility treatment. Main issues of ART” was conducted in Astana, on 28-29th of October 2011. |
| 04.06.2011 |
The International Conference in Reproductive medicine “Management IVF-clinic: comprehensive approach” was conducted in Kiev, on 3rd of June, 2011. |
| 02.04.2011 |
From 1st of April, 2011 Merck Serono S.A., Switzerland, authorized and gave exclusive rights to Sona-Pharm LLC to represent pharmaceutical products (Gonal-f, Ovitrelle, Cetrotide, Crinone, Luveris) on the territory of Republic of Kazakhstan. |
| 29.05.2010 |
ESHRE CAMPUS SYMPOSIUM and Congress of Reproductive Health of Ukraine «The management of infertility – training workshop for junior doctors, paramedicals and embryologists». |
|
|
| |
SEARCH |
 |
15.11.2011
04.06.2011
02.04.2011
29.05.2010
21.05.2010
|
